USSubmitted label - approval not established

GENETONE OIL (IGNATIA, BELLIS PER,, ARNICA MONT., STAPHYSAGRIA, CANNABIS IND., GELSIMIUM, TEREBINTHINA, CAMPHOR OFF.) OIL

This is a locally preserved regulatory record. Source labeling does not by itself prove efficacy for a condition.

Submitted product label. A product label is preserved locally, but approval or current marketing status is not established.

Product data

Locally preserved regulatory fields

Active ingredients: Source-reported ingredients: cannabis, TEREBINTHONE, ARNICA MONTANA, DELPHINIUM STAPHISAGRIA WHOLE · 4 more
cannabis, TEREBINTHONE, ARNICA MONTANA, DELPHINIUM STAPHISAGRIA WHOLE, CAMPHOR LEAF OIL, GELSEMINE, STRYCHNOS IGNATII SEED, BELLIS PERENNIS
Route: Not reported
Dosage form: Not reported
Marketing holder: DR. MASOOD HOMEOPATHIC PHARMACEUTICALS PRIVATE LIMITED
Catalog status: Submitted label - approval not established
Source-reported status: Not reported

Linked local records

Related local records

Substance links use source-reported active ingredients. Condition links come from registered study context and are not efficacy claims.

Cannabinoids and active compounds

Camphor

Condition reports

epilepsy Chronic Pain Anxiety Disorders Cancer Pain Stress Disorders, Post-Traumatic Migraine Disorders Opioid-Related Disorders Depressive Disorder

Regulatory record

Approval, patents and exclusivity

Patent and exclusivity fields are preserved from the regulator. They are not a legal opinion and are separate from clinical development.

0approval records

0source-reported patents

0exclusivity records

Clinical development

Related registered studies

Phases and statuses are source-reported study stages matched by governed token phrases. They do not prove medicine identity, approval or efficacy.

370candidate study links

PHASE2SUSPENDED

Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans

DRUG · Placebo Cannabis

Cannabis · Pain · Tolerance · Hyperalgesia

PHASE2SUSPENDED

Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans

DRUG · Active Cannabis

Cannabis · Pain · Tolerance · Hyperalgesia

PHASE1RECRUITING

Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes

DRUG · Cannabis

Cannabis Intoxication

NACOMPLETED

Evaluación de Una Herramienta E-Salud Para la reducción Del Consumo de Cannabis

BEHAVIORAL · CANreduce

Cannabis Use Disorder

PHASE2 · PHASE3COMPLETED

A Phase II/III Double-Blind, Randomised and Controlled-to-Open-Label Study Assessing the Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) on the Severity of Autism Spectrum Disorder in Young People

DRUG · NTI164

Autism Spectrum Disorder

PHASE1RECRUITING

Source-reported use

Indications in regulatory records

No indication text was reported by the connected sources.

Medicine identity matching

RxNorm candidates

RxNorm normalizes identity; FAERS supplies non-causal post-market signals.

Identity candidate · score 16.51468849182129

CAMPHOR OIL

Matched from: GENETONE OIL (IGNATIA, BELLIS PER,, ARNICA MONT., STAPHYSAGRIA, CANNABIS IND., GELSIMIUM, TEREBINTHINA, CAMPHOR OFF.) OIL

Official RxNorm record

Identity candidate · score 5.4594794423546675

RxNorm concept

Matched from: GELSEMINE

Official RxNorm record

Identity candidate · score 14.079368791132914

RxNorm concept

Matched from: DELPHINIUM STAPHISAGRIA WHOLE

Official RxNorm record

Identity candidate · score 6.664053772764174

Gelsemium sempervirens preparation

Matched from: GELSEMINE

Official RxNorm record

Identity candidate · score 10.16157242457072

RxNorm concept

Matched from: DELPHINIUM STAPHISAGRIA WHOLE

Official RxNorm record

Identity candidate · score 19.359891001383463

Strychnos ignatii preparation

Matched from: STRYCHNOS IGNATII SEED

Official RxNorm record

Safety signals

Locally preserved FAERS reports

0reports

0reported as serious

FAERS/AEMS reports are post-market signals. Counts do not establish causality or incidence and may contain duplicates or reporting bias.

Sources and provenance

Official source snapshots

DailyMed structured labels

16c318bd-5949-866c-e063-6294a90aadcb · version 1

Retrieved 22/08/2026, 21:20:19Verify at source

Locally preserved regulatory fields

Related local records

Cannabinoids and active compounds

Condition reports

Approval, patents and exclusivity

Related registered studies

Indications in regulatory records

RxNorm candidates

CAMPHOR OIL

RxNorm concept

RxNorm concept

Gelsemium sempervirens preparation

RxNorm concept

Strychnos ignatii preparation

Locally preserved FAERS reports

Official source snapshots

DailyMed structured labels

Bellis perennis flower extract

TEREBINTHONE

Cannabis indica top

RxNorm concept

RxNorm concept

Delphinium staphisagria seed extract

Strychnos nux-vomica whole extract

camphor / menthol Topical Oil

Arnica montana flower

BELLIS PERENNIS 200 [hp_C] ORAL PELLET [Bellis perennis Kit Refill]

camphor Topical Oil

ASPIRIN/CAFFEINE/GELSEMIUM/HYOSCYAMUS

RxNorm concept

RxNorm concept

Gelsemium sempervirens root extract

RxNorm concept

RxNorm concept

Strychnos mitis whole extract

FLAXSEED WHOLE

BELLIS PERENNIS LEAF

RxNorm concept

GELSEMINE

Strychnos nux-vomica seed extract

Cannabis indica

RxNorm concept

Strychnos ignatii seed extract

Delphinium staphisagria whole extract

RxNorm concept

BELLIS PERENNIS 30 [hp_C] ORAL PELLET [Bellis perennis Kit Refill]

Arnica montana flower water

Arnica montana

BELLIS PERENNIS 200 [hp_C] in 1 mL ORAL LIQUID